Drug Discovery News and Research

RSS
The drug discovery process begins with recognizing a disease or clinical condition in which there is a lack of adequate medical treatment. Once a potential drug has been identified, pre-clinical research can begin. This process includes several stages; the first of which involves identifying and validating the prospective drug’s target through assay development, high throughput screening, hit identification and finally, lead optimization. Once the pre-clinical process is complete, the newly synthesized drug candidate is selected for future clinical development.
Phase 1 trial for EBC-129 progresses into dose expansion

Phase 1 trial for EBC-129 progresses into dose expansion

Non-hormonal sperm-specific approach offers a promising option for reversible male contraception

Non-hormonal sperm-specific approach offers a promising option for reversible male contraception

Insilico Medicine's leadership to address key challenges in AI drug discovery at BIO Convention

Insilico Medicine's leadership to address key challenges in AI drug discovery at BIO Convention

Breakthrough study reveals molecular drivers of Alzheimer's progression

Breakthrough study reveals molecular drivers of Alzheimer's progression

API processes in the pharmaceutical industry

API processes in the pharmaceutical industry

New drug-like molecules show promise in preventing influenza by blocking virus entry

New drug-like molecules show promise in preventing influenza by blocking virus entry

Novel therapy reprograms immune cells, shrinks prostate and bladder cancers in animal study

Novel therapy reprograms immune cells, shrinks prostate and bladder cancers in animal study

ERS Genomics and IRBM sign CRISPR/Cas9 license agreement

ERS Genomics and IRBM sign CRISPR/Cas9 license agreement

New CRISPR screen method reveals cellular drivers of neurological disorders

New CRISPR screen method reveals cellular drivers of neurological disorders

World's first human mini-brain with a fully functional blood-brain barrier developed

World's first human mini-brain with a fully functional blood-brain barrier developed

Insilico and NVIDIA unveil new LLM transformer for solving biological and chemical tasks

Insilico and NVIDIA unveil new LLM transformer for solving biological and chemical tasks

Cancer researchers urged to embrace AI for groundbreaking insights and efficiency

Cancer researchers urged to embrace AI for groundbreaking insights and efficiency

AlphaFold2 can be an effective tool in structure-based drug discovery

AlphaFold2 can be an effective tool in structure-based drug discovery

Innovative DL4MicEverywhere platform revolutionizes microscopy image analysis with AI

Innovative DL4MicEverywhere platform revolutionizes microscopy image analysis with AI

RedShiftBio launches Aurora TX: Revolutionizing RNA and protein analysis with ultra-sensitive microfluidic modulation spectroscopy and thermal ramping capability

RedShiftBio launches Aurora TX: Revolutionizing RNA and protein analysis with ultra-sensitive microfluidic modulation spectroscopy and thermal ramping capability

Enhanc3D Genomics appoints Hazel Jones as Chief Executive Officer

Enhanc3D Genomics appoints Hazel Jones as Chief Executive Officer

Optibrium partners with FMC Corporation to transform agrochemical discovery

Optibrium partners with FMC Corporation to transform agrochemical discovery

New diagnostic and treatment approach could revolutionize bladder cancer care

New diagnostic and treatment approach could revolutionize bladder cancer care

Purdue researcher receives $2.4 million NIH grant to combat antimicrobial resistance in lung infections

Purdue researcher receives $2.4 million NIH grant to combat antimicrobial resistance in lung infections

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.